| Product Code: ETC11389291 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Anticoagulants Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Anticoagulants Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Anticoagulants Market - Industry Life Cycle |
3.4 Sweden Anticoagulants Market - Porter's Five Forces |
3.5 Sweden Anticoagulants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Anticoagulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Sweden Anticoagulants Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Sweden Anticoagulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Sweden |
4.2.2 Growing aging population leading to higher incidence of thromboembolic disorders |
4.2.3 Technological advancements in anticoagulant therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of anticoagulant drugs |
4.3.2 High cost associated with anticoagulant treatments |
4.3.3 Potential side effects and complications of anticoagulant therapies |
5 Sweden Anticoagulants Market Trends |
6 Sweden Anticoagulants Market, By Types |
6.1 Sweden Anticoagulants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Anticoagulants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Sweden Anticoagulants Market Revenues & Volume, By Direct Oral Anticoagulants, 2021 - 2031F |
6.1.4 Sweden Anticoagulants Market Revenues & Volume, By Vitamin K Antagonists, 2021 - 2031F |
6.1.5 Sweden Anticoagulants Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.2 Sweden Anticoagulants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Sweden Anticoagulants Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Sweden Anticoagulants Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Sweden Anticoagulants Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Sweden Anticoagulants Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.3 Sweden Anticoagulants Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.3.4 Sweden Anticoagulants Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
7 Sweden Anticoagulants Market Import-Export Trade Statistics |
7.1 Sweden Anticoagulants Market Export to Major Countries |
7.2 Sweden Anticoagulants Market Imports from Major Countries |
8 Sweden Anticoagulants Market Key Performance Indicators |
8.1 Patient adherence rate to anticoagulant treatment |
8.2 Number of new anticoagulant drug approvals in Sweden |
8.3 Rate of adoption of novel anticoagulant therapies |
8.4 Average length of hospital stay for patients receiving anticoagulant treatment |
8.5 Number of anticoagulant-related adverse events reported |
9 Sweden Anticoagulants Market - Opportunity Assessment |
9.1 Sweden Anticoagulants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Anticoagulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Sweden Anticoagulants Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Sweden Anticoagulants Market - Competitive Landscape |
10.1 Sweden Anticoagulants Market Revenue Share, By Companies, 2024 |
10.2 Sweden Anticoagulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here